Biogen Inc. buy Royal Bank of Canada
Start price
02.08.24
/
50%
€188.45
Target price
02.08.25
€267.50
Performance (%)
0.00%
Price
02.08.24
€188.45
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada is currently unchanged from the start price. This prediction currently runs until 02.08.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Biogen Inc. | 0.00% |
iShares Core DAX® | -3.935% |
iShares Nasdaq 100 | -3.608% |
iShares Nikkei 225® | -4.513% |
iShares S&P 500 | -2.607% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Royal Bank of Canada from $282.00 to $292.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat